Summary
Although a long held tenet of biology has been that endogenous inhibitors can modulate cell proliferation, little progress was made in purifying any such inhibitor. This was largely due to the rarity of non-malignant cell cultures in which regulation of cell division was still operative, and to problems in separating cytotoxic and cytostatic effects in the complex biological extracts which were being studied. During the last decade, hepatic proliferation inhibitors of varying degrees of purity have been isolated using regenerating rat liver or hepatoma cell cultures as test systems. In these early studies, a number of inhibitors with differing molecular weights, physicochemical properties and biological responses were purified from liver cytosol and/or serum. Some of them could inhibit DNA synthesis or mitosis and thus were considered to be G1 or G2 inhibitors. However, experiments which could give precise answers about mechanisms of action could not be done until an inhibitor purified to homogeneity was available.
Using well-characterized rat liver diploid epithelial cell cultures, which maintain a number of liver properties and which do not possess any transformation markers or malignant properties, we recently purified an hepatic proliferation inhibitor to a homogenous protein. It has a molecular weight of 26 000 daltons and an isoelectric point of 4.65. It specifically inhibits cell division and DNA synthesis in a number of non-malignant rat liver epithelial cell types, and has no effect on transformed liver cells, or hepatoma cells, in culture. Its effect is not mediated through destruction or sequestration of essential nutrients or calcium ions. Nor have preliminary experiments shown the hepatic proliferation inhibitor to interfere with the binding of epidermal growth factor to its receptors. The majority of the cells treated with the inhibitor are blocked in the G1 phase. Further experiments to study its mechanism of action and the inter-relationship, if any, between the cell cycle block induced by serum or nutrient deprivation, and the inhibitor-induced cycle block are in progress.
Similar content being viewed by others
References
Allen, J. C., 1978. Nature 276: 669.
Allen, T. D. and Iype, P. T., 1979. J. Cancer Res. Clin. Oncol. 95: 225–232.
Allen, T. D., Iype, P. T. and Murphy, M. J., 1976. In Vitro 12: 837–844.
Antoniades, H. N. and Owen, A. J., 1982. Ann. Rev. Med. 33: 445–463.
Aujard, C., Chany, E. & Frayssinet, C., 1973. Expt. Cell Res. 78: 476–478.
Baldwin, R. W. and Barker, C. R., 1967. Br. J. Cancer 21: 793–800.
Barbason, H., Fridman-Manduzio, A., Lelievre, P. and Betz, E. H., 1977. Eur. J. Cancer 13: 13–18.
Barbason, H. and Betz, E. H., 1980. Eur. J. Cancer 17: 149–154.
Barra, R., Parsons, J., Koch, M. R. and Lea, M. A., 1979. Cancer Res. 39: 1655–1660.
Berman, A., Ellouz, R., Lenfant, M. and Garcia-Giralt, E., 1975. C.R. Acad. Sci. Paris 281: 187–190.
Bowen-Pope, D. F., Vidair, C., Sanui, H. and Rubin, A. H., 1979. Proc. Natl. Acad. Sci. U.S.A. 76: 1308–1312.
Brodsky, W. Y. and Uryvaeva, I. V., 1977. Int. Rev. Cytol. 50: 275–332.
Bruscalupi, G., Curatola, G., Lenaz, G., Leoni, S., Mangiantini, M. T., Mazzanti, L., Spagnuolo, S. and Trentalanse, A., 1980. Biochim. Biophys. Acta 597: 263–273.
Bucher, N. L. R., 1963. Int. Rev. Cytol. 15: 245–300.
Bullough, W. S., 1975. Biol. Rev. 50: 99–127.
Campisi, J., Medrano, E. E., Morreo, G. and Pardee, A. B., 1982. Proc. Natl. Acad. Sci. U.S.A. 79: 436–440.
Cannella, N. K., 1977. Life Sci. 20: 155–158.
Cook, R. T., Roetman, K. J. and Steinmetz, G., 1982. Cell Biol. Intl. Rep. b: 49–56.
DePaermentier, F., Barbason, H. and Bassleer, R., 1979. Biologic Cellulaire 34: 205–211.
Deschamps, Y. and Verly, W. G., 1975. Biomedicine 22: 195–208.
Freed, J. J. and Sorof, S., 1967. Wistar Symposium Monograph No. 7, pp. 15–24.
Gospodarowicz, D. and Fujii, D. K., 1981. Cellular Responses to Molecular Modulators (Mozes, L. W., et al., eds.), pp. 113–135, Academic Press, New York.
Hatase, O., Fugii, T., Kuramitsu, M., Itano, T., Takahashi, F., Murakami, T. and Nisida, I, 1979. Acta Med. Okayama 33: 73–80.
Harrington, W. N. and Godman, G. C., 1980. Proc. Natl. Acad. Sci. U.S.A. 77: 423–427.
Herring, A. S., Raychaudhuri, R., Kelley, S. P. and Iype, P. T., 1983. In Vitro 19: 576–588.
Higgins, G. M. and Anderson, R. M., 1931. Arch. Pathol. 12:182–202.
Holley, R. W., 1967. Biochim. Biophys. Acta 145: 523–525.
Holley, R. W., 1975. Nature 258: 487–490.
Holley, R. W., Armour, R. and Baldwin, J. H., 1978. Proc. Natl. Acad. Sci. U.S.A. 75: 339–341.
Inaba, K., Doi, A. and Nisida, L, 1977. Cell Struct. Funct. 2: 155–158.
Iversen, O. H., 1981. Handbook of Experimental Pharmacology (Baserga, R., ed.), Vol. 57, pp. 491–550, Springer, New York.
Iype, P. T., 1971. J. Cell Physiol. 78: 281–288.
Iype, P. T., 1980. Cell Movement and Neoplasia (De Brabander M. et al., eds.), pp. 79–85, Pergamon Press, Oxford and New York.
Type, P. T. and Allen, T. D., 1979. Cancer Lett. 6: 27–32.
Iype, P. T., Allen, T. D. and Pillinger, D. J., 1975. Gene Expression and Carcinogenesis in Cultured Liver (Greschenson, L. E. and Thompson, E. B., eds.), pp. 425–440, Academic Press, New York.
Iype, P. T., Baldwin, R. W. and Glaves, D., 1972. Br. J. Cancer 26: 6–9.
Iype, P. T., Currens, M.J. Herring, A., Kelley, S. P., McMahon, J. B., Ray-Chaudhuri, R. and Malan-Shibley, L., 1982. Proc. Am. Assoc. Cancer Res. 23: 74.
Iype, P. T., Herring, A., Ray-Chadhuri, R. and Kelley, S., 1983. In Vitro Toxicity Testing of Environmental Agents: Current and Future Possibilities (Kolber, A. R. et al., eds.), pp. 337A–354A, Plenum Press, New York.
Iype, P. T., Issaq, H. J. and Shaikh, B., 1982. J. Steroid Biochem. 16: 333–337.
Iype, P. T. and McMahon, J. B., 1981. Cancer Res. 41: 3352–3354.
Iype, P. T. and Pontzer, C. H., 1980. Cancer Res. 40: 4663–4668.
Iype, P. T., Tomaszewski, J. E. and Dipple, A., 1979. Cancer Res. 39: 4925–4929.
Iype, P. T., Turner, S. and Siddiqi, M. S., 1980. Annal. N.Y. Acad. Sci. 349: 312–322.
Ketlinskii, S. A. and Parfenova, E. V., 1981. Bull. Exp. Biol. Med. 92: 971–973.
Kuo, C. Y. and Yoo, T. J., 1977. J. Natl. Cancer Inst. 59: 1691–1695.
Kuramitsu, M., Matsui, H., Tokuda, M. and Hatase, O., 1982. Acta Med. Okayama 36: 1–10.
Lafarge-Frayssinet, C., Mousset, S. and Frayssinet, C., 1981. Biomedicine 34: 99–102.
Lavigne, J., Lalanne, M., Thompson, J. P. and Simard, A., 1977. Rev. Can. Biol. 36: 27–36.
Lenfant, M., Kren-Proschek, L., Verly, W. G. and Dugas, H., 1973. Can. J. Biochem. 51: 654–665.
Liberman, I. and Ove, P., 1960. Biochim. Biophys. Acta 38: 153.
Lipkin, G., Rosenberg, M. and Knecht, M. E., 1976. Biochem. Pharmacol. 25: 1333–1337.
Loginov, A. S., Speranskii, M. D., Aruin, L. I., Matyushina, E. D. and Magnitskii, G. S., 1976. Bull. Exp. Biol. Med. 82: 1482–1484.
Lozzio, S. B., Lozzio, D. B., Bamberger, E. G. and Lair, S. V., 1975. Int. Rev. Cytol. 42: 1–47.
Malan-Shibley, L. and Iype, P. T., 1981. Exptl. Cell Res. 131: 363–371.
McMahon, J. B., Farrelly, J. G. and Iype, P. T., 1982. Proc. Natl. Acad. Sci. U.S.A. 79: 456–460.
McMahon, J. B. and Iype, P. T., 1980. Cancer Res. 40: 1249–1254, 1980.
McMahon, J. B. and Iype, P. T., 1982. J. Liq. Chromatog. 5: 751–756.
McMahon, J. B., Kelleher, P. C. and Smith, C. J., 1977. Biochem. Biophys. Res. Commun. 76: 1144–1150.
Menzies, R. A. and Kerrigan, J. M., 1974. Exptl. Cell Res. 86: 430–433.
Menyhart, J., Marcsek, Z. and Grof, J., 1981. Acta Physiol. Acad. Sci. Hungaricae 58: 119–129.
Meyers, D. J., Yancey, S. B. and Revel, J.-P., 1981. J. Cell Biol. 91: 505–523.
Miyamoto, M. and Terayama, H., 1971. Biochim. Biophys. Acta 228: 324–330.
Molimard, R., Pietu, G., Chany, E., Trincal, G. and Frayssinet, C., 1975. Biomedicine 23: 434–437.
Moses, H. L., Proper, J. A., Volkenant, M. E. and Swartzendruber, D. E., 1980. J. Cell. Physiol. 102: 367–378.
Murray, A. B., Strecker, W. and Silz, S., 1981. J. Cell Sci. 50: 433–448.
Nadal, C., 1973. Cell Tiss. Kinet. 6: 437–446.
Nadal, C., 1975. Virchows Arch. B. Cell Path. 18: 273–280.
Nadal, C., 1979. Arch. Toxicol Suppl. 2: 131–142.
Nadal, C. and Boffa, G. A., 1975. Cell Tiss. Kinet. 8: 297–305.
Nadal, C. and Le Rumeur, E., 1981. Cell Tiss. Kinet. 14: 331–335.
Nadal, C., LeRumeur, E. and Boffa, G. A., 1981. Cell Tiss. Kinet. 14: 601–609.
Nadal, C., Lombard, M. N. and Zajdela, F., 1976. Virchows Arch. B. Cell Pathol. 20: 277–285.
Onda, H., 1977. Gann 68: 301–306.
Onda, H., 1979. J. Theor. Biol. 77: 367–377.
Onda, H. and Yoshikawa, J., 1973. Gann 64: 139–149.
Onda, H. and Yoshikawa, J., 1974. Gann 65: 139–144.
Onda, H. and Yoshikawa, J., 1975. Gann 66: 227–235.
Patt, L. M. and Houck, J. C., 1980. FEBS Lett. 120: 163–170.
Pietu, G., Chany, E., Molimard, R. and Frayssinet, C., 1978. Biomedicine 28: 169–175.
Pietu, G., Munsch, N., Mousset, S. and Frayssinet, C., 1979. Cell Tiss. Kinet. 12: 153–160.
Potter, V. R., 1980. Yale J. Biol. Med. 53: 367–384.
Potter, V. R., 1981. Oncodevelopmental Biology and Medicine 2: 243–266.
Potter, V. R., 1981. Carcinogenesis 2: 1375–1379.
RayChaudhuri, R., Kelley, S. P. and Iype, P. T., 1980. Carcinogenesis 1: 779–785.
Rossow, P. W., Riddle, V. G. H. and Pardee, A. B., 1979. Proc. Natl. Acad. Sci. U.S.A. 76: 4446–4450.
Rudland, P. S. and De Asua, L. J., 1979. Biochim. Biophys. Acta 560: 91–133.
Scott, R. E., Florine, D. L., Wille, J. J. Jr. and Yun, K., 1982. Proc. Natl. Acad. Sci. U.S.A. 79: 845–849.
Sekas, G. and Cook, R. T., 1976. Exptl. Cell Res. 102: 422–425.
Sekas, G., Owen, W. G. and Cook, R. T., 1979. Exptl. Cell Res. 122: 47–54.
Siddiqi, M. and Iype, P. T., 1975. Int. J. Cancer 15: 773–780.
Simard, A., Corneille, L., Deschamps, Y. and Verly, W. G., 1974. Proc. Natl. Acad. Sci. U.S.A. 71: 1763–1766.
Sonnenschein, C. and Soto, A. M., 1981. Proc. Natl. Acad. Sci. U.S.A. 78: 3702–3705.
Sporn, M. B. and Todaro, G. J., 1980. New Engl. J. Med. 303: 878–881.
Stoker, M. G. P., 1974. Control of Proliferation in Animal Cells (Clarkson, B. and Baserga, R., eds.), pp. 1009–1013, Cold Spring Harbor.
Stoker, M., 1981. Cellular Responses to Molecular Modulators (Moses, L. W. et al., eds.), pp. 39–48, Academic Press, New York.
Sunkara, P. S., Pargac, M. B., Nishioka, K. and Rao, P. N., 1979. J. Cell Physiol. 98: 451–458.
Sunkara, P. S., Rao, P. N., Nishioka, K. and Brinkley, B. R., 1979. Exptl. Cell Res. 119: 63–68.
Swierenga, S. H. H., Whitfield, J. F. and Karasaki, S., 1978. Proc. Natl. Acad. Sci. U.S.A. 75: 6069–6072.
Thaler, M. M. and Pickart, L. R., 1975. Gene Expression and Carcinogenesis in Cultured Liver (Greschenson, L. E. and Thompson, E. G., eds.), pp. 292–310. Academic Press, New York.
Thomas, G., Martin-Pérez, J., Siegmann, M. and Otto, A. M., 1982. Cell 30: 235–242.
Tulloch, B. R., Lee, S. and Iype, P. T., 1979. Clin. Res. 27: 261a.
Umansky, S. R., 1982. J. Theor. Biol. 97: 591–602.
Verly, W. G., 1976. Chalones (Houck, J. C., ed.), pp. 401–428, North-Holland Publishing Co., Amsterdam.
Verly, W. G., Deschamps, Y., Pushpathadam, J. and Desrosiers, M., 1971. Can. J. Biochem. 49: 1376–1383.
Vinet, B. and Verly, W. G., 1976. Eurp. J. Cancer 12: 211–218.
Wille, J. J. Jr., Maercklein, P. B. and Scott, R. E., 1982. Cancer Res. 42: 5139–5146.
Yamaguchi, N. and Weinstein, I. B., 1975. Proc. Natl. Acad. Sci. U.S.A. 72: 214–218.
Yen, A. and Pardee, A. B., 1978. Exptl. Cell Res. 116: 103–113.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thomas Iype, P., McMahon, J.B. Hepatic proliferation inhibitor. Mol Cell Biochem 59, 57–80 (1984). https://doi.org/10.1007/BF00231305
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00231305